Business Venture Investments 790 (Pty) Ltd and Afrox Healthcare Limited (105/LM/Dec05) [2005] ZACT 28; [2005] 1 CPLR 192 (CT) (9 May 2005)

Business Venture Investments 790 (Pty) Ltd and Afrox Healthcare Limited (105/LM/Dec05) [2005] ZACT 28; [2005] 1 CPLR 192 (CT) (9 May 2005)

The Tribunal found that the proposed merger, while facilitating significant black economic empowerment, presented material horizontal and vertical competition concerns. Mvelaphanda's and IDC's cross-holdings in competing hospital groups created risks of anti-competitive information exchange and coordination, necessitating divestiture and board resignations. The vertical relationship between RMB (through FirstRand) and Discovery Holdings, a major medical scheme administrator, raised concerns about potential foreclosure and collusion, warranting notification of any increase in RMB's equity stake above 25% as a large merger. The Tribunal was not satisfied by assurances from the parties...

Citation
[2005] ZACT 28
Parties
Applicant: Business Venture Investments 790 (Pty) Ltd; Respondent: Afrox Healthcare Limited; Respondent: Competition Commission
Court
Competition Tribunal
Jurisdiction
South Africa
Judgment Date
9 May 2005
Case Number
105/LM/Dec04
Procedural Posture
Large Merger Review / Conditional Approval With Reasons
Outcome
Merger conditionally approved subject to divestiture, board resignations, and future notification requirements.
Judges
David Lewis, Norman Manoim, Thandi Orleyn
Legal Topics
Large Merger Notification, Horizontal Overlap, Vertical Integration, Cross Holdings Divestiture, Public Interest Bee, Future Disposal Restrictions
Competition Law Commercial and Corporate Large Merger Notification Horizontal Overlap Vertical Integration Cross Holdings Divestiture Public Interest Bee Future Disposal Restrictions

Case Brief

Summary, issues, holding and outcome

More case intelligence is available

Unlock the full research layer for this judgment.

Full judgment text Downloadable case file Legal principles 4 Authorities cited 2 Party arguments 2 Amounts and remedies 1
Sign in to unlock

Parties

Business Venture Investments 790 (Pty) Ltd

Applicant

Afrox Healthcare Limited

Respondent

Competition Commission

Respondent

Procedural Posture

Large Merger Review / Conditional Approval With Reasons

Legal Issues

  1. 1 Whether the proposed merger raises substantial horizontal or vertical competition concerns in the private hospital market.
  2. 2 Whether cross-holdings and board representation among competitors create risks of anti-competitive information exchange.
  3. 3 Whether vertical integration between hospital ownership and medical scheme administration poses competition risks.

Ratio Decidendi

The Tribunal found that the proposed merger, while facilitating significant black economic empowerment, presented material horizontal and vertical competition concerns. Mvelaphanda's and IDC's cross-holdings in competing hospital groups created risks of anti-competitive information exchange and coordination, necessitating divestiture and board resignations. The vertical relationship between RMB (through FirstRand) and Discovery Holdings, a major medical scheme administrator, raised concerns about potential foreclosure and collusion, warranting notification of any increase in RMB's equity stake above 25% as a large merger. The Tribunal was not satisfied by assurances from the parties...

Court Disposition

Merger conditionally approved subject to divestiture, board resignations, and future notification requirements.

Orders

  • The merger is approved in terms of section 16(2)(b) of the Competition Act subject to the following conditions:
  • Mvelaphanda must dispose of its entire shareholding in Tshwane Private Hospitals within three months or as approved by competition authorities.